Compounds > pk 11195
Page last updated: 2024-10-21

pk 11195 and Malignant Melanoma

pk 11195 has been researched along with Malignant Melanoma in 1 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gyrylova, SN1
Ruksha, TG1
Komina, AV1

Other Studies

1 other study available for pk 11195 and Malignant Melanoma

ArticleYear
[TSPO ligand PK11195 and MAPK inhibitor UO126 modulate tspo expression level].
    Tsitologiia, 2013, Volume: 55, Issue:2

    Topics: Butadienes; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; MAP Kin

2013